1206 related articles for article (PubMed ID: 32535032)
1. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
2. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection.
Faul JL; Kerley CP; Love B; O'Neill E; Cody C; Tormey W; Hutchinson K; Cormican LJ; Burke CM
Ir Med J; 2020 May; 113(5):84. PubMed ID: 32603575
[No Abstract] [Full Text] [Related]
4. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
5. Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?
Rafiullah M
Am J Med Sci; 2020 Oct; 360(4):338-341. PubMed ID: 32736832
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol.
Quesada-Gomez JM; Lopez-Miranda J; Entrenas-Castillo M; Casado-Díaz A; Nogues Y Solans X; Mansur JL; Bouillon R
Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807895
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
8. [Vitamin D and coronavirus: a new field of use?].
Maestri E; Formoso G; Da Cas R; Mammarella F; Guerrizio MA; Trotta F
Recenti Prog Med; 2020 Apr; 111(4):253-256. PubMed ID: 32319447
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
Arboleda JF; Urcuqui-Inchima S
Front Immunol; 2020; 11():1523. PubMed ID: 32655583
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
11. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
[No Abstract] [Full Text] [Related]
12. Vitamin D and COVID-19: Lessons from Spaceflight Analogs.
Zwart SR; Smith SM
J Nutr; 2020 Oct; 150(10):2624-2627. PubMed ID: 32710111
[No Abstract] [Full Text] [Related]
13. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
14. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
Soto M; diZerega G; Rodgers KE
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
[TBL] [Abstract][Full Text] [Related]
15. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.
Grant WB; Lahore H; McDonnell SL; Baggerly CA; French CB; Aliano JL; Bhattoa HP
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32252338
[TBL] [Abstract][Full Text] [Related]
16. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3 as Potential Treatment Adjuncts for COVID-19.
Malaguarnera L
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33202670
[TBL] [Abstract][Full Text] [Related]
19. Does vitamin D deficiency increase the severity of COVID-19?
Weir EK; Thenappan T; Bhargava M; Chen Y
Clin Med (Lond); 2020 Jul; 20(4):e107-e108. PubMed ID: 32503801
[TBL] [Abstract][Full Text] [Related]
20. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
